Activin A is a homodimeric glycoprotein involved in embryonic development, stem cell regulation, inflammation, and bone metabolism. It is primarily studied as a therapeutic target due to its involvement in various disease processes like fibrosis and cachexia.
In the literature, Activin A appears most often in work focused on inflammation, cellular repair and bone health. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Activin A is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
BMP-2 (Bone Morphogenetic Protein 2) is a potent osteoinductive growth factor essential for bone repair. Recombinant human BMP-2 is used clinically to promote bone growth in orthopedic procedures.
An EPO-derived peptide studied for neuropathic pain, small fiber neuropathy, and tissue protection.
A blend of GHK-Cu, BPC-157, TB-500, and KPV studied for combined skin, gut, and tissue repair research.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.